4 completed, 1 active not recruiting, 1 recruiting. 5 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Completed 3, Active not recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Memory Decline: new trials by email Literature Review of Memory Decline trials Research Report on Memory Decline
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| In-Person Recruitment of Individuals to the Alzheimer's Prevention Trial (APT) Webstudy Financial Incentive, Active Comparator #1 - Memory Decline, Healthy Subjects | Not applicable | Completed | University of Southern California | 209 | 2025-06-09 | 2026-09-15 |
| Music for the Mind Study Piano lessons, Music Lessons - Mild Cognitive Impairment (MCI), Memory Disorders, Age Related | Not applicable | Completed | University of Rochester | 19 | 2025-02-24 | 2026-04-08 |
| Optimizing CNS DHA Delivery in Elderly Adults at Risk for Dementia LPC-EPA+DHA capsules containing omega-3 fatty acids EPA and DHA esterified to lysophosphatidylcholine (LPC-EPA+DHA)(Trade name: Lysoveta) - Eldery People, Cognitive Decline | Not applicable | Recruiting | University of Cincinnati | 153 | 2024-09-15 | 2026-08-19 |
| Anti-inflammatory Probiotics in Cognitive Functioning Probiotic Supplementation (Bifidobacterium longum Rosell®-175 & Lactobacillus helveticus Rosell®-52) then placebo, Placebo Supplementation then Probiotic Supplementation (Bifidobacterium longum Rosell®-175 & Lactobacillus helveticus Rosell®-52) - Memory Decline, Cognitive Decline | Not applicable | Active not recruiting | University of Social Sciences and Humanities, Warsaw | 110 | 2024-01-25 | 2025-09-17 |
| Noninvasive Brain Stimulation for Mild Cognitive Impairment Active rTMS (Bilateral DLPFC), Active rTMS (Bilateral LPC), Placebo rTMS (Inactive) - Mild Cognitive Impairment, Mild Neurocognitive Disorder | Not applicable | Completed | Palo Alto Veterans Institute for Research | 69 | 2018-06-15 | 2025-09-03 |
| Effect of Panax Ginseng on the Cognitive Performance in Alzheimer's Disease Panax Ginseng - Alzheimer's Disease, Memory Decline | Phase 1 / Phase 2 | Completed | Seoul National University Hospital | 2004-04-01 | 2006-10-24 |
Cognitive Dysfunction (4) · Memory Disorders (2) · Alzheimer Disease (1) · Neurocognitive Disorders (1)
Mental Disorders (5) · Cognition Disorders (4) · Neurocognitive Disorders (4) · Nervous System Diseases (3) · Neurobehavioral Manifestations (2) · Neurologic Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Dementia (1) · Neurodegenerative Diseases (1) · Tauopathies (1)
Asian ginseng (1)
Palo Alto Veterans Institute for Research (1) · Seoul National University Hospital (1) · University of Cincinnati (1) · University of Rochester (1) · University of Social Sciences and Humanities, Warsaw (1) · University of Southern California (1)
United States (4) · Poland (1)
Joy L Taylor, Ph.D. (1) · Manho Kim, MD, PhD (1) · Mireille Jaocbson, PhD (1) · Robert McNamara, PhD (1)
R01AG055526 (1)